Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Elshot YS"'
Autor:
Elshot YS; Department of Dermatology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Lasso Peña DJP; Department of Dermatology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Zupan-Kajcovski B; Department of Dermatology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Bekkenk MW; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Balm AJM; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Klop WMC; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., de Rie MA; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Jun 26. Date of Electronic Publication: 2024 Jun 26.
Autor:
Bruijn TVM; Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands.; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Geraedts A; Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands., Vlahu CA; Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands., Jaspars LH; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Elshot YS; Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands.; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Publikováno v:
JAAD case reports [JAAD Case Rep] 2024 Mar 08; Vol. 47, pp. 41-43. Date of Electronic Publication: 2024 Mar 08 (Print Publication: 2024).
Autor:
Ingen-Housz-Oro S; Dermatology Department, AP-HP, Henri Mondor Hospital, Univ Paris Est Créteil EpiDermE, Créteil, France.; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil, France.; Dermatology for Cancer Patients EADV Task Force, Toulouse, France., Elshot YS; Dermatology for Cancer Patients EADV Task Force, Toulouse, France.; Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Segura S; Dermatology for Cancer Patients EADV Task Force, Toulouse, France.; Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra, Barcelona, Spain., Marchand A; Dermatology for Cancer Patients EADV Task Force, Toulouse, France.; Dermatology Unit, Department of Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Pouessel D; Oncology Department, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France., Kluger N; Dermatology for Cancer Patients EADV Task Force, Toulouse, France.; Dermatology Department, Helsinki University Hospital, Helsinki, Finland., de Barros Silva G; Dermatology for Cancer Patients EADV Task Force, Toulouse, France.; Dermatology Department, Hospital 12 de Octubre, Madrid, Spain., Ortiz-Brugues A; Dermatology for Cancer Patients EADV Task Force, Toulouse, France.; Oncology Department, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France., Aubert M; Oncology Department, AP-HP, Henri Mondor Hospital, Créteil, France., Saldana C; Oncology Department, AP-HP, Henri Mondor Hospital, Créteil, France.; Univ Paris Est Creteil, TRePCa, Créteil, France., Mavroudis D; Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Crete, Greece., Burle E; Oncology Department, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France., Tournier E; Department of Pathology, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France., Koumaki D; Dermatology for Cancer Patients EADV Task Force, Toulouse, France.; Department of Dermatology and Venereology, University Hospital of Heraklion, Crete, Greece., Sibaud V; Dermatology for Cancer Patients EADV Task Force, Toulouse, France.; Oncology Department, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Jan; Vol. 38 (1), pp. e99-e101. Date of Electronic Publication: 2023 Aug 29.
Autor:
Elshot YS; Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Postbus 90203, 1006 BE, Amsterdam, the Netherlands; Department of Dermatology, Amsterdam UMC, Univ. of Amsterdam, Postbus 22660, 1100 DD, Amsterdam, the Netherlands. Electronic address: y.elshot@amsterdamumc.nl., Bruijn TVM; Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Postbus 90203, 1006 BE, Amsterdam, the Netherlands; Department of Dermatology, Amsterdam UMC, Univ. of Amsterdam, Postbus 22660, 1100 DD, Amsterdam, the Netherlands., Ouwerkerk W; Department of Dermatology, Amsterdam UMC, Univ. of Amsterdam, Postbus 22660, 1100 DD, Amsterdam, the Netherlands; Amsterdam Infection & Immunity Institute, Cancer Center, Univ. of Amsterdam, Postbus 22660, 1100 DD, Amsterdam, the Netherlands., Jaspars LH; Department of Pathology, Amsterdam UMC, Univ. of Amsterdam, Postbus 22660, 1100 DD, Amsterdam, the Netherlands., van de Wiel BA; Department of Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Postbus 90203, 1006 BE, Amsterdam, Netherlands., Zupan-Kajcovski B; Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Postbus 90203, 1006 BE, Amsterdam, the Netherlands., de Rie MA; Department of Dermatology, Amsterdam UMC, Univ. of Amsterdam, Postbus 22660, 1100 DD, Amsterdam, the Netherlands., Bekkenk MW; Department of Dermatology, Amsterdam UMC, Univ. of Amsterdam, Postbus 22660, 1100 DD, Amsterdam, the Netherlands., Balm AJM; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Postbus 90203, 1006 BE, Amsterdam, Netherlands; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, Univ. of Amsterdam, the Netherlands., Klop WMC; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Postbus 90203, 1006 BE, Amsterdam, Netherlands; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, Univ. of Amsterdam, the Netherlands.
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2023 Nov; Vol. 49 (11), pp. 107053. Date of Electronic Publication: 2023 Sep 19.
Autor:
Reijers ILM; Department of Medical Oncology, Netherlands Cancer Institute , Amsterdam, Netherlands., Rao D; Molecular Oncology and Immunology, Netherlands Cancer Institute , Amsterdam, Netherlands., Versluis JM; Department of Medical Oncology, Netherlands Cancer Institute , Amsterdam, Netherlands., Menzies AM; Melanoma Institute Australia, The University of Sydney , Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney , Sydney, Australia.; Department of Medical Oncology, Royal North Shore and Mater Hospitals , Sydney, Australia., Dimitriadis P; Molecular Oncology and Immunology, Netherlands Cancer Institute , Amsterdam, Netherlands., Wouters MW; Department of Surgical Oncology, Netherlands Cancer Institute , Amsterdam, Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center , Leiden, Netherlands., Spillane AJ; Melanoma Institute Australia, The University of Sydney , Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney , Sydney, Australia.; Department of Breast and Melanoma Surgery, Royal North Shore and Mater Hospitals , Sydney, Australia., Klop WMC; Department of Head and Neck Surgical Oncology, Netherlands Cancer Institute , Amsterdam, Netherlands., Broeks A; Core Facility and Molecular Pathology & Biobanking department, Netherlands Cancer Institute , Amsterdam, Netherlands., Bosch LJW; Pathology and Molecular Diagnostics Department, Netherlands Cancer Institute , Amsterdam, Netherlands., Lopez-Yurda M; Biometrics Department, Netherlands Cancer Institute , Amsterdam, Netherlands., van Houdt WJ; Department of Surgical Oncology, Netherlands Cancer Institute , Amsterdam, Netherlands., Rawson RV; Melanoma Institute Australia, The University of Sydney , Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney , Sydney, Australia.; Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology , Sydney, Australia., Grijpink-Ongering LG; Biometrics Department, Netherlands Cancer Institute , Amsterdam, Netherlands., Gonzalez M; Melanoma Institute Australia, The University of Sydney , Sydney, Australia., Cornelissen S; Core Facility and Molecular Pathology & Biobanking department, Netherlands Cancer Institute , Amsterdam, Netherlands., Bouwman J; Pathology and Molecular Diagnostics Department, Netherlands Cancer Institute , Amsterdam, Netherlands., Sanders J; Core Facility and Molecular Pathology & Biobanking department, Netherlands Cancer Institute , Amsterdam, Netherlands., Plasmeijer E; Department of Dermatology, Netherlands Cancer Institute , Amsterdam, Netherlands.; Department of Dermatology, Leiden University Medical Center , Leiden, Netherlands., Elshot YS; Department of Dermatology, Netherlands Cancer Institute , Amsterdam, Netherlands.; Department of Dermatology, Amsterdam UMC, University of Amsterdam , Amsterdam, Netherlands., Scolyer RA; Melanoma Institute Australia, The University of Sydney , Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney , Sydney, Australia.; Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology , Sydney, Australia.; Charles Perkins Centre, The University of Sydney , Sydney, Australia., van de Wiel BA; Department of Pathology, Netherlands Cancer Institute , Amsterdam, Netherlands., Peeper DS; Molecular Oncology and Immunology, Netherlands Cancer Institute , Amsterdam, Netherlands., van Akkooi ACJ; Melanoma Institute Australia, The University of Sydney , Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney , Sydney, Australia.; Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital , Sydney, Australia., Long GV; Melanoma Institute Australia, The University of Sydney , Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney , Sydney, Australia.; Department of Medical Oncology, Royal North Shore and Mater Hospitals , Sydney, Australia.; Charles Perkins Centre, The University of Sydney , Sydney, Australia., Blank CU; Department of Medical Oncology, Netherlands Cancer Institute , Amsterdam, Netherlands.; Molecular Oncology and Immunology, Netherlands Cancer Institute , Amsterdam, Netherlands.; Department of internal medicine, Leiden University Medical Center , Leiden, Netherlands.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2023 May 01; Vol. 220 (5). Date of Electronic Publication: 2023 Mar 15.
Autor:
Elshot YS; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Tio DCKS; Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., van Haersma-de With ASE; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Ouwerkerk W; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Amsterdam Infection & Immunity Institute, Cancer Center, University of Amsterdam, Amsterdam, The Netherlands.; National Heart Centre Singapore, Singapore, Singapore., Zupan-Kajcovski B; Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Crijns MB; Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Limpens CEJM; Research Support, Medical Library, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Klop WMC; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Bekkenk MW; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Balm AJM; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., de Rie MA; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2023 May; Vol. 37 (5), pp. 871-883. Date of Electronic Publication: 2023 Jan 31.
Autor:
Elshot YS; Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Postbus 90203, 1006 BE, Amsterdam, the Netherlands; Department of Dermatology, Amsterdam UMC, Univ. of Amsterdam, Postbus 22660, 1100 DD, Amsterdam, the Netherlands. Electronic address: y.elshot@amsterdamumc.nl., Zupan-Kajcovski B; Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Postbus 90203, 1006 BE, Amsterdam, the Netherlands., Ouwerkerk W; Department of Dermatology, Amsterdam UMC, Univ. of Amsterdam, Postbus 22660, 1100 DD, Amsterdam, the Netherlands; Amsterdam Infection & Immunity Institute, Cancer Center, Univ. of Amsterdam, Postbus 22660, 1100 DD, Amsterdam, the Netherlands., Klop WMC; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Postbus 90203, 1006 BE, Amsterdam, the Netherlands; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, Univ. of Amsterdam, Postbus 22660, 1100 DD, Amsterdam, the Netherlands., Lohuis PJFM; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Postbus 90203, 1006 BE, Amsterdam, the Netherlands; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, Univ. of Amsterdam, Postbus 22660, 1100 DD, Amsterdam, the Netherlands., Bol M; Department of Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Postbus 90203, 1006 BE, Amsterdam, the Netherlands., Crijns MB; Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Postbus 90203, 1006 BE, Amsterdam, the Netherlands., Bekkenk MW; Department of Dermatology, Amsterdam UMC, Univ. of Amsterdam, Postbus 22660, 1100 DD, Amsterdam, the Netherlands., de Rie MA; Department of Dermatology, Amsterdam UMC, Univ. of Amsterdam, Postbus 22660, 1100 DD, Amsterdam, the Netherlands., Balm AJM; Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Postbus 90203, 1006 BE, Amsterdam, the Netherlands; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, Univ. of Amsterdam, Postbus 22660, 1100 DD, Amsterdam, the Netherlands.
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2023 Apr; Vol. 49 (4), pp. 818-824. Date of Electronic Publication: 2022 Aug 18.
Autor:
Ingen-Housz-Oro S; Dermatology Department, AP-HP, Henri Mondor Hospital.; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil.; FISARD Group, Paris.; Univ Paris est Créteil EpidermE, Créteil.; European Task Force 'Dermatology for Cancer Patients', EADV, Toulouse.; ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris., Milpied B; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil.; FISARD Group, Paris.; European Task Force 'Dermatology for Cancer Patients', EADV, Toulouse.; ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris.; Dermatology Department, CHU Bordeaux, Bordeaux., Badrignans M; Pathology Department, AP-HP, Henri Mondor Hospital, Créteil.; Université Paris Est Créteil Val de Marne UPEC, Créteil, France., Carrera C; European Task Force 'Dermatology for Cancer Patients', EADV, Toulouse.; Dermatology Department, Hospital Clínic Barcelona, University of Barcelona, Barcelona.; CIBERER Centro de Investigaciones Biomedicas en Red de Enfermedades Raras Insituto de Salud Carlos III, Valencia.; Pharmacovigilance Technical Committee, Hospital Clinic Barcelona, Barcelona, Spain., Elshot YS; European Task Force 'Dermatology for Cancer Patients', EADV, Toulouse.; Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek.; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Bensaid B; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil.; FISARD Group, Paris.; Dermatology Department, CHU Edouard Herriot, Lyon, France., Segura S; European Task Force 'Dermatology for Cancer Patients', EADV, Toulouse.; Dermatology Department, Hospital del Mar, Universitat Pompeu Fabra, Barcelona, Spain., Apalla Z; European Task Force 'Dermatology for Cancer Patients', EADV, Toulouse.; Second Dermatology Department, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece., Markova A; European Task Force 'Dermatology for Cancer Patients', EADV, Toulouse.; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center.; Department of Dermatology, Weill Cornell Medical College, New York, New York, USA., Staumont-Sallé D; FISARD Group, Paris.; Dermatology Department, CHU Lille, University Lille, INFINITE U1286 Inserm, Lille, France., Marti-Marti I; European Task Force 'Dermatology for Cancer Patients', EADV, Toulouse.; Dermatology Department, Hospital Clínic Barcelona, University of Barcelona, Barcelona., Giavedoni P; European Task Force 'Dermatology for Cancer Patients', EADV, Toulouse.; Dermatology Department, Hospital Clínic Barcelona, University of Barcelona, Barcelona., Chua SL; ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris.; Department of Dermatology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Darrigade AS; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil.; FISARD Group, Paris.; Dermatology Department, CHU Bordeaux, Bordeaux., Dezoteux F; FISARD Group, Paris.; Dermatology Department, CHU Lille, University Lille, INFINITE U1286 Inserm, Lille, France., Starace M; European Task Force 'Dermatology for Cancer Patients', EADV, Toulouse.; Dermatology-IRCCS Policlinico di Sant'Orsola - Department of Experimental, Diagnostic and Specialty Medicine (DIMES) Alma Mater Studiorum University of Bologna, Bologna, Italy., Torre AC; European Task Force 'Dermatology for Cancer Patients', EADV, Toulouse.; Dermatology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Riganti J; European Task Force 'Dermatology for Cancer Patients', EADV, Toulouse.; Dermatology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., de Prost N; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil.; Intensive Care Unit, AP-HP, Henri Mondor Hospital, Créteil., Lebrun-Vignes B; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil.; FISARD Group, Paris.; ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris.; Regional Pharmacovigilance Center, AP-HP, Pitié-Salpêtrière Hospital, Paris., Bauvin O; FISARD Group, Paris.; Dermatology Department, CHU Charles Nicolle, Rouen, France., Walsh S; ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris.; Department of Dermatology, King's College Hospital, London, UK., Ortonne N; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil.; Pathology Department, AP-HP, Henri Mondor Hospital, Créteil.; Université Paris Est Créteil Val de Marne UPEC, Créteil, France., French LE; ToxiTEN Group, European Reference Network for Rare Skin Diseases, Paris.; Department of Dermatology and Allergy, University Hospital, Ludwig Maximilan University (LMU) Munich, Munich, Germany.; Dr. Philip Frost, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA., Sibaud V; European Task Force 'Dermatology for Cancer Patients', EADV, Toulouse.; Department of Oncodermatology, Claudius Regaud Institute and University Cancer Institute Toulouse Oncopole, Toulouse, France.
Publikováno v:
Melanoma research [Melanoma Res] 2022 Jun 01; Vol. 32 (3), pp. 205-210. Date of Electronic Publication: 2022 Mar 29.
Autor:
Uitentuis SE; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Bambach C; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands., Elshot YS; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.; Department of Dermatology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Limpens J; Medical Library, University of Amsterdam, Amsterdam, the Netherlands., van Akkooi ACJ; Department of Surgical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Bekkenk MW; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Publikováno v:
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] [Dermatol Surg] 2022 Apr 01; Vol. 48 (4), pp. 387-394.
Autor:
Woliner-van der Weg W; Departments of, Department of, Dermatology, Radboud University Medical Centre, Nijmegen, the Netherlands., Peppelman M; Departments of, Department of, Dermatology, Radboud University Medical Centre, Nijmegen, the Netherlands., Elshot YS; Department of Dermatology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Dermatology, Amsterdam University Medical Centres, Amsterdam, the Netherlands., Visch MB; Department of Dermatology, Rijnstate Hospital, Arnhem, the Netherlands., Crijns MB; Department of Dermatology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Alkemade HAC; Department of Dermatology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands., Bronkhorst EM; Department of, Health Evidence, Radboud University Medical Centre, Nijmegen, the Netherlands., Adang E; Department of, Health Evidence, Radboud University Medical Centre, Nijmegen, the Netherlands., Amir A; Department of, Pathology, Radboud University Medical Centre, Nijmegen, the Netherlands., Gerritsen MJP; Departments of, Department of, Dermatology, Radboud University Medical Centre, Nijmegen, the Netherlands., van Erp PEJ; Departments of, Department of, Dermatology, Radboud University Medical Centre, Nijmegen, the Netherlands., Lubeek SFK; Departments of, Department of, Dermatology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Publikováno v:
The British journal of dermatology [Br J Dermatol] 2021 Apr; Vol. 184 (4), pp. 663-671. Date of Electronic Publication: 2020 Sep 02.